DexCom, Inc.
DXCM
$89.53
$1.882.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.31B | 1.19B | 1.26B | 1.21B | 1.16B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.31B | 1.19B | 1.26B | 1.21B | 1.16B |
| Cost of Revenue | 478.40M | 441.60M | 466.90M | 477.90M | 468.30M |
| Gross Profit | 830.00M | 750.30M | 792.70M | 731.40M | 688.80M |
| SG&A Expenses | 358.70M | 349.70M | 321.50M | 331.40M | 328.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 990.10M | 936.60M | 936.60M | 966.80M | 944.50M |
| Operating Income | 318.30M | 255.30M | 323.00M | 242.50M | 212.60M |
| Income Before Tax | 317.50M | 269.50M | 340.70M | 352.30M | 241.10M |
| Income Tax Expenses | 68.40M | 70.00M | 73.40M | 68.50M | 61.30M |
| Earnings from Continuing Operations | 249.10M | 199.50M | 267.30M | 283.80M | 179.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 249.10M | 199.50M | 267.30M | 283.80M | 179.80M |
| EBIT | 318.30M | 255.30M | 323.00M | 242.50M | 212.60M |
| EBITDA | 386.50M | 322.40M | 388.20M | 306.10M | 275.60M |
| EPS Basic | 0.65 | 0.52 | 0.69 | 0.73 | 0.46 |
| Normalized Basic EPS | 0.52 | 0.44 | 0.55 | 0.56 | 0.38 |
| EPS Diluted | 0.64 | 0.51 | 0.68 | 0.70 | 0.45 |
| Normalized Diluted EPS | 0.51 | 0.43 | 0.53 | 0.54 | 0.37 |
| Average Basic Shares Outstanding | 382.20M | 385.10M | 386.70M | 391.10M | 392.10M |
| Average Diluted Shares Outstanding | 390.10M | 393.60M | 398.90M | 407.40M | 408.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |